Annual Short Term Debt
$541.60 K
-$5.10 M-90.40%
December 31, 2022
Summary
- As of February 10, 2025, LMNL annual short term debt is $541.60 thousand, with the most recent change of -$5.10 million (-90.40%) on December 31, 2022.
- During the last 3 years, LMNL annual short term debt has fallen by -$5.93 million (-91.63%).
Performance
LMNL Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Short Term Debt
$512.40 K
-$14.70 K-2.79%
June 30, 2023
Summary
- As of February 10, 2025, LMNL quarterly short term debt is $512.40 thousand, with the most recent change of -$14.70 thousand (-2.79%) on June 30, 2023.
- Over the past year, LMNL quarterly short term debt has dropped by -$6.88 million (-93.07%).
Performance
LMNL Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
LMNL Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -90.4% | -93.1% |
| 3 y3 years | -91.6% | -91.8% |
| 5 y5 years | -89.7% | -75.7% |
LMNL Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.4% | at low | -93.1% | at low |
| 5 y | 5-year | -91.6% | at low | -93.1% | at low |
| alltime | all time | -91.9% | -86.4% | -94.7% | -94.8% |
Liminal BioSciences Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $512.40 K(-2.8%) |
| Mar 2023 | - | $527.10 K(-2.7%) |
| Dec 2022 | $541.60 K(-90.4%) | $541.60 K(+3.0%) |
| Sep 2022 | - | $525.70 K(-92.9%) |
| Jun 2022 | - | $7.40 M(+10.7%) |
| Mar 2022 | - | $6.68 M(+18.4%) |
| Dec 2021 | $5.64 M(+3.6%) | $5.64 M(-17.7%) |
| Sep 2021 | - | $6.86 M(+14.8%) |
| Jun 2021 | - | $5.97 M(+8.0%) |
| Mar 2021 | - | $5.53 M(+1.6%) |
| Dec 2020 | $5.45 M(-15.8%) | $5.45 M(-1.5%) |
| Sep 2020 | - | $5.53 M(-11.6%) |
| Jun 2020 | - | $6.26 M(+29.8%) |
| Mar 2020 | - | $4.82 M(-25.6%) |
| Dec 2019 | $6.47 M(-2.6%) | $6.47 M(-9.1%) |
| Sep 2019 | - | $7.12 M(+1.8%) |
| Jun 2019 | - | $7.00 M(-27.7%) |
| Mar 2019 | - | $9.68 M(+45.6%) |
| Dec 2018 | $6.65 M(+26.0%) | $6.65 M(+94.3%) |
| Sep 2018 | - | $3.42 M(+62.2%) |
| Jun 2018 | - | $2.11 M(-48.5%) |
| Mar 2018 | - | $4.10 M(-22.4%) |
| Dec 2017 | $5.28 M(+4.6%) | $5.28 M(+5.0%) |
| Sep 2017 | - | $5.03 M(+27.6%) |
| Jun 2017 | - | $3.94 M(-23.5%) |
| Mar 2017 | - | $5.15 M(+2.0%) |
| Dec 2016 | $5.05 M(+1148.6%) | $5.05 M(+3692.6%) |
| Sep 2016 | - | $133.10 K(+58.1%) |
| Jun 2016 | - | $84.20 K(-79.2%) |
| Dec 2015 | $404.30 K(-85.8%) | $404.30 K(-86.7%) |
| Jun 2014 | - | $3.05 M(+5.7%) |
| Mar 2014 | - | $2.88 M(+1.0%) |
| Dec 2013 | $2.86 M(-49.5%) | $2.86 M(-55.6%) |
| Sep 2013 | - | $6.43 M(+108.4%) |
| Jun 2013 | - | $3.08 M(-31.9%) |
| Mar 2013 | - | $4.53 M(-19.9%) |
| Dec 2012 | $5.65 M(+35.0%) | $5.65 M(+146.6%) |
| Sep 2012 | - | $2.29 M(-30.8%) |
| Jun 2012 | - | $3.31 M(+2.8%) |
| Mar 2012 | - | $3.22 M(-23.1%) |
| Dec 2011 | $4.19 M(+44.3%) | $4.19 M(+135.8%) |
| Sep 2011 | - | $1.78 M(+15.0%) |
| Jun 2011 | - | $1.54 M(+64.8%) |
| Mar 2011 | - | $937.30 K(-67.7%) |
| Dec 2010 | $2.90 M(-24.4%) | $2.90 M(-47.0%) |
| Sep 2010 | - | $5.47 M(+33.0%) |
| Jun 2010 | - | $4.12 M(-27.6%) |
| Mar 2010 | - | $5.68 M(+48.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $3.84 M(-1.7%) | $3.84 M(+4.4%) |
| Sep 2009 | - | $3.68 M(-10.5%) |
| Jun 2009 | - | $4.11 M(-15.1%) |
| Mar 2009 | - | $4.84 M(+23.8%) |
| Dec 2008 | $3.91 M(+9.5%) | $3.91 M(-26.2%) |
| Sep 2008 | - | $5.29 M(-1.0%) |
| Jun 2008 | - | $5.35 M(+14.6%) |
| Mar 2008 | - | $4.66 M(+30.7%) |
| Dec 2007 | $3.57 M(+55.5%) | $3.57 M(+9.0%) |
| Sep 2007 | - | $3.28 M(+12.1%) |
| Jun 2007 | - | $2.92 M(+26.1%) |
| Mar 2007 | - | $2.32 M(+1.0%) |
| Dec 2006 | $2.30 M(+39.1%) | $2.30 M(-40.1%) |
| Sep 2006 | - | $3.83 M(-28.1%) |
| Jun 2006 | - | $5.33 M(+161.5%) |
| Mar 2006 | - | $2.04 M(+23.5%) |
| Dec 2005 | $1.65 M(+35.1%) | $1.65 M(-5.9%) |
| Sep 2005 | - | $1.75 M(-14.8%) |
| Jun 2005 | - | $2.06 M(+71.1%) |
| Mar 2005 | - | $1.20 M(-1.6%) |
| Dec 2004 | $1.22 M(+224.0%) | $1.22 M(+232.3%) |
| Sep 2004 | - | $367.80 K(-1.1%) |
| Jun 2004 | - | $371.90 K(-4.4%) |
| Mar 2004 | - | $389.20 K(+3.2%) |
| Dec 2003 | $377.20 K(+296.6%) | $377.20 K(+21.6%) |
| Sep 2003 | - | $310.10 K(+3.6%) |
| Jun 2003 | - | $299.30 K(+30.8%) |
| Mar 2003 | - | $228.90 K(+140.7%) |
| Dec 2002 | $95.10 K(+28.9%) | $95.10 K(+2.1%) |
| Sep 2002 | - | $93.10 K(+2.5%) |
| Jun 2002 | - | $90.80 K(+240.1%) |
| Sep 2001 | - | $26.70 K(-33.7%) |
| Jun 2001 | - | $40.30 K(-27.5%) |
| Mar 2001 | - | $55.60 K(-24.7%) |
| Dec 2000 | $73.80 K(-46.3%) | $73.80 K(-33.2%) |
| Sep 2000 | - | $110.40 K(-18.2%) |
| Jun 2000 | - | $135.00 K(-2.0%) |
| Mar 2000 | - | $137.70 K(+0.1%) |
| Dec 1999 | $137.50 K(-95.5%) | $137.50 K(+101.9%) |
| Sep 1999 | - | $68.10 K(-98.6%) |
| Jun 1999 | - | $4.87 M(+24.6%) |
| Mar 1999 | - | $3.91 M(+28.8%) |
| Dec 1998 | $3.04 M(+319.4%) | $3.04 M(+208.5%) |
| Sep 1998 | - | $984.30 K(-3.8%) |
| Jun 1998 | - | $1.02 M(+142.7%) |
| Mar 1998 | - | $421.50 K(+0.7%) |
| Dec 1997 | - | $418.60 K |
| Sep 1997 | $724.00 K | - |
FAQ
- What is Liminal BioSciences annual short term debt?
- What is the all time high annual short term debt for Liminal BioSciences?
- What is Liminal BioSciences annual short term debt year-on-year change?
- What is Liminal BioSciences quarterly short term debt?
- What is the all time high quarterly short term debt for Liminal BioSciences?
- What is Liminal BioSciences quarterly short term debt year-on-year change?
What is Liminal BioSciences annual short term debt?
The current annual short term debt of LMNL is $541.60 K
What is the all time high annual short term debt for Liminal BioSciences?
Liminal BioSciences all-time high annual short term debt is $6.65 M
What is Liminal BioSciences annual short term debt year-on-year change?
Over the past year, LMNL annual short term debt has changed by -$5.10 M (-90.40%)
What is Liminal BioSciences quarterly short term debt?
The current quarterly short term debt of LMNL is $512.40 K
What is the all time high quarterly short term debt for Liminal BioSciences?
Liminal BioSciences all-time high quarterly short term debt is $9.68 M
What is Liminal BioSciences quarterly short term debt year-on-year change?
Over the past year, LMNL quarterly short term debt has changed by -$6.88 M (-93.07%)